Extension of Time to File SOU

PROLANZA

Inventia Healthcare Limited

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88818199
LAW OFFICE ASSIGNED LAW OFFICE 127
MARK SECTION
MARK PROLANZA (see, http://uspto.report/TM/88818199/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT PROLANZA
OWNER SECTION ( 1st owner)(current)
NAME LAILA NUTRACEUTICALS
INTERNAL ADDRESS 40-15-14 Brindavan Colony, Labbipet
MAILING ADDRESS Vijayawada
CITY Andhra Pradesh
ZIP/POSTAL CODE 520010
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY India
EMAIL XXXX
OWNER SECTION ( 1st owner) (proposed)
NAME LAILA NUTRACEUTICALS
INTERNAL ADDRESS 40-15-14 Brindavan Colony, Labbipet
MAILING ADDRESS Vijayawada
CITY Andhra Pradesh
ZIP/POSTAL CODE 520010
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY India
EMAIL XXXX
OWNER SECTION ( 2nd owner)(current)
NAME Inventia Healthcare Limited
INTERNAL ADDRESS Unit 703, 704, 7th Flr, Hubtown Solaris
MAILING ADDRESS N S Phadke Marg, Andheri (East)
CITY Mumbai
ZIP/POSTAL CODE 400069
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY India
EMAIL XXXX
OWNER SECTION ( 2nd owner) (proposed)
NAME Inventia Healthcare Limited
INTERNAL ADDRESS Unit 703, 704, 7th Flr, Hubtown Solaris
MAILING ADDRESS N S Phadke Marg, Andheri (East)
CITY Mumbai
ZIP/POSTAL CODE 400069
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY India
EMAIL XXXX
OWNER SECTION ( 3rd owner)(current)
NAME NattoPharma ASA
MAILING ADDRESS Lilleakerveien 2B
CITY Oslo
ZIP/POSTAL CODE 0283
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Norway
EMAIL XXXX
OWNER SECTION ( 3rd owner) (proposed)
NAME NattoPharma ASA
MAILING ADDRESS Lilleakerveien 2B
CITY Oslo
ZIP/POSTAL CODE 0283
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Norway
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Mark David Torche
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@patwrite.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) melissa@patwrite.com
CORRESPONDENCE INFORMATION (proposed)
NAME Mark David Torche
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@patwrite.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) melissa@patwrite.com; mtorche@gmail.com
DOCKET/REFERENCE NUMBER 1801235-010
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Ashwagandha sold as an integral component of nutritional supplements, dietary supplements, mineral supplements, herbal supplements, and vitamin supplements for use in foods, beverages and cosmetics
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 05/11/2021
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /mark david torche/
SIGNATORY'S NAME Mark David Torche
SIGNATORY'S POSITION Attorney of record, New York Bar member
DATE SIGNED 11/09/2021
SIGNATORY'S PHONE NUMBER 641-753-3995
SIGNATURE METHOD Signed directly within the form
FILING INFORMATION
SUBMIT DATE Tue Nov 09 12:16:05 ET 2021
TEAS STAMP USPTO/ESU-XXX.XX.XXX.XXX-
20211109121605379749-8881
8199-781ffc67cb65258b64c7
d824327f187c57e238ddae0fe
12e98a324995fe579974-ET-1
6032318-20211109121134931
813



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: PROLANZA (see, http://uspto.report/TM/88818199/mark.png)
SERIAL NUMBER: 88818199

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: LAILA NUTRACEUTICALS, having an address of
      40-15-14 Brindavan Colony, Labbipet
      Vijayawada
      Andhra Pradesh, 520010
      India
      Email: XXXX
Proposed: LAILA NUTRACEUTICALS, having an address of
      40-15-14 Brindavan Colony, Labbipet
      Vijayawada
      Andhra Pradesh, 520010
      India
      Phone:
      Fax:
      Email: XXXX
Current: Inventia Healthcare Limited, having an address of
      Unit 703, 704, 7th Flr, Hubtown Solaris
      N S Phadke Marg, Andheri (East)
      Mumbai, 400069
      India
      Email: XXXX
Proposed: Inventia Healthcare Limited, having an address of
      Unit 703, 704, 7th Flr, Hubtown Solaris
      N S Phadke Marg, Andheri (East)
      Mumbai, 400069
      India
      Phone:
      Fax:
      Email: XXXX
Current: NattoPharma ASA, having an address of
      Lilleakerveien 2B
      Oslo, 0283
      Norway
      Email: XXXX
Proposed: NattoPharma ASA, having an address of
      Lilleakerveien 2B
      Oslo, 0283
      Norway
      Phone:
      Fax:
      Email: XXXX

The owners requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 05/11/2021.

For International Class 005:
Current identification: Ashwagandha sold as an integral component of nutritional supplements, dietary supplements, mineral supplements, herbal supplements, and vitamin supplements for use in foods, beverages and cosmetics

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Mark David Torche
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@patwrite.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): melissa@patwrite.com

Correspondence Information (proposed):
      Mark David Torche
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@patwrite.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): melissa@patwrite.com; mtorche@gmail.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /mark david torche/      Date Signed: 11/09/2021
Signatory's Name: Mark David Torche
Signatory's Position: Attorney of record, New York Bar member
Signatory's Phone: 641-753-3995
Signature method: Signed directly within the form

PAYMENT: 88818199
PAYMENT DATE: 11/09/2021

Serial Number: 88818199
Internet Transmission Date: Tue Nov 09 12:16:05 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XXX-202111091216053
79749-88818199-781ffc67cb65258b64c7d8243
27f187c57e238ddae0fe12e98a324995fe579974
-ET-16032318-20211109121134931813




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed